|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yamashita T, Budhu A, Forgues M and Wang
XW: Activation of hepatic stem cell marker EpCAM by
Wnt-beta-catenin signaling in hepatocellular carcinoma. Cancer Res.
67:10831–10839. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Azechi H, Nishida N, Fukuda Y, Nishimura
T, Minata M, Katsuma H, Kuno M, Ito T, Komeda T, Kita R, et al:
Disruption of the p16/cyclin D1/retinoblastoma protein pathway in
the majority of human hepatocellular carcinomas. Oncology.
60:346–354. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sudo T, Utsunomiya T, Mimori K, Nagahara
H, Ogawa K, Inoue H, Wakiyama S, Fujita H, Shirouzu K and Mori M:
Clinicopathological significance of EZH2 mRNA expression in
patients with hepatocellular carcinoma. Br J Cancer. 92:1754–1758.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schmidt CM, McKillop IH, Cahill PA and
Sitzmann JV: Increased MAPK expression and activity in primary
human hepatocellular carcinoma. Biochem Biophys Res Commun.
236:54–58. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huynh H, Nguyen TT, Chow KH, Tan PH, Soo
KC and Tran E: Over-expression of the mitogen-activated protein
kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: Its
role in tumor progression and apoptosis. BMC Gastroenterol.
8:32003.
|
|
7
|
Newell P, Toffanin S, Villanueva A, Chiang
DY, Minguez B, Cabellos L, Savic R, Hoshida Y, Lim KH,
Melgar-Lesmes P, et al: Ras pathway activation in hepatocellular
carcinoma and anti-tumoral effect of combined sorafenib and
rapamycin in vivo. J Hepatol. 51:725–733. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liang Y, Yang Z and Zhong R: Primary
biliary cirrhosis and cancer risk: A systematic review and
meta-analysis. Hepatology. 56:1409–1417. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park YN, Chae KJ, Kim YB, Park C and
Theise N: Apoptosis and proliferation in hepatocarcinogenesis
related to cirrhosis. Cancer. 92:2733–2738. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Laouirem S, Le Faouder J, Alexandrov T,
Mestivier D, Léger T, Baudin X, Mebarki M, Paradis V, Camadro JM
and Bedossa P: Progression from cirrhosis to cancer is associated
with early ubiquitin post-translational modifications:
Identification of new biomarkers of cirrhosis at risk of
malignancy. J Pathol. 234:452–463. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Arrieta O, Rodriguez-Diaz JL,
Rosas-Camargo V, Morales-Espinosa D, de Leon S Ponce, Kershenobich
D and Leon-Rodriguez E: Colchicine delays the development of
hepatocellular carcinoma in patients with hepatitis virus-related
liver cirrhosis. Cancer. 107:1852–1858. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu DC, Liu J, Chen J, Shao JJ, Shen X, Xia
HG, Li CJ, Xue B and Ding YT: GGPPS1 predicts the biological
character of hepatocellular carcinoma in patients with cirrhosis.
Bmc Cancer. 14:2482014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nam SW, Park JY, Ramasamy A, Shevade S,
Islam A, Long PM, Park CK, Park SE, Kim SY, Lee SH, et al:
Molecular changes from dysplastic nodule to hepatocellular
carcinoma through gene expression profiling. Hepatology.
42:809–818. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Villanueva A, Hoshida Y, Battiston C,
Tovar V, Sia D, Alsinet C, Cornella H, Liberzon A, Kobayashi M,
Kumada H, et al: Combining clinical, pathology, and gene expression
data to predict recurrence of hepatocellular carcinoma.
Gastroenterology. 140:1501–1512.e2. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jia HL, Ye QH, Qin LX, Budhu A, Forgues M,
Chen Y, Liu YK, Sun HC, Wang L, Lu HZ, et al: Gene expression
profiling reveals potential biomarkers of human hepatocellular
carcinoma. Clin Cancer Res. 13:1133–1139. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. Bmc
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dennis G, Sherman BT, Hosack DA, Yang J,
Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kanehisa M, Goto S, Sato Y, Furumichi M
and Tanabe M: KEGG for integration and interpretation of
large-scale molecular data sets. Nucleic Acids Res. 40:D109–D114.
2011.PubMed/NCBI
|
|
20
|
Merico D, Isserlin R, Stueker O, Emili A
and Bader GD: Enrichment Map: A network-based method for gene-set
enrichment visualization and interpretation. PloS One.
5:e139842010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang B and Horvath S: A general framework
for weighted gene co-expression network analysis. Stat Appl Genet
Mol Biol. 4:Article172005.PubMed/NCBI
|
|
23
|
Yeung OW, Lo CM, Ling CC, Qi X, Geng W, Li
CX, Ng KT, Forbes SJ, Guan XY, Poon RT, et al: Alternatively
activated (M2) macrophages promote tumour growth and invasiveness
in hepatocellular carcinoma. J Hepatol. 62:607–616. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang P, Li QJ, Feng Y, Zhang Y, Markowitz
GJ, Ning S, Deng Y, Zhao J, Jiang S, Yuan Y, et al:
TGF-β-miR-34a-CCL22 signaling-induced treg cell recruitment
promotes venous metastases of HBV-positive hepatocellular
carcinoma. Cancer Cell. 22:291–303. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Budhu A and Wang XW: Transforming the
microenvironment: A trick of the metastatic cancer cell. Cancer
Cell. 22:279–280. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hsing C-H, Cheng HC, Hsu YH, Chan CH, Yeh
CH, Li CF and Chang MS: Upregulated IL-19 in breast cancer promotes
tumor progression and affects clinical outcome. Clin Cancer Res.
18:713–725. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo X, Yanna, Ma X, An J, Shang Y, Huang
Q, Yang H, Chen Z and Xing J: A meta-analysis of array-CGH studies
implicates antiviral immunity pathways in the development of
hepatocellular carcinoma. Plos One. 6:e284042011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Oleksyk TK, Thio CL, Truelove AL, Goedert
JJ, Donfield SM, Kirk GD, Thomas DL, O'Brien SJ and Smith MW:
Single nucleotide polymorphisms and haplotypes in the IL10 region
associated with HCV clearance. Genes Immun. 6:347–357. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu P, Keller JR, Ortiz M, Tessarollo L,
Rachel RA, Nakamura T, Jenkins NA and Copeland NG: Bcl11a is
essential for normal lymphoid development. Nat Immunol. 4:525–532.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Satterwhite E, Sonoki T, Willis TG, Harder
L, Nowak R, Arriola EL, Liu H, Price HP, Gesk S, Steinemann D, et
al: The BCL11 gene family: Involvement of BCL11A in lymphoid
malignancies. Blood. 98:3413–3420. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jiang B, Zhang X, Su J, Meng W, Yang XN,
Yang JJ, Zhou Q, Chen ZY, Chen ZH, Xie Z, et al: BCL11A
overexpression predicts survival and relapse in non-small cell lung
cancer and is modulated by microRNA-30a and gene amplification. Mol
Cancer. 12:612013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ip YC, Cheung ST, Lee YT, Ho JC and Fan
ST: Inhibition of hepatocellular carcinoma invasion by suppression
of claudin-10 in HLE cells. Mol Cancer Ther. 6:2858–2867. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cheung ST, Leung KL, Ip YC, Chen X, Fong
DY, Ng IO, Fan ST and So S: Claudin-10 expression level is
associated with recurrence of primary hepatocellular carcinoma.
Clin Cancer Res. 11:551–556. 2005.PubMed/NCBI
|
|
34
|
Zheng A, Yuan F, Li Y, Zhu F, Hou P, Li J,
Song X, Ding M and Deng H: Claudin-6 and claudin-9 function as
additional coreceptors for hepatitis C virus. J Virol.
81:12465–12471. 2007. View Article : Google Scholar : PubMed/NCBI
|
